Ratings Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Real-time Euronext Paris 14:16:11 19/06/2024 BST 5-day change 1st Jan Change
52.78 EUR -1.01% Intraday chart for Eurofins Scientific SE -4.69% -10.51%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-10.51% 11.04B
A-
+25.85% 89.22B
C+
-22.73% 76.59B
B-
+3.24% 26.87B
C+
-9.15% 17.41B
B
+0.96% 17.32B
A-
-0.42% 15.25B
A-
+81.96% 13.43B
C+
+72.40% 13.26B
C-
-23.33% 13.01B - -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ERF Stock
  4. Ratings Eurofins Scientific SE
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW